Company Information
- Type:
- Company
- Country:
- Türkiye
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Delisted
- Reason for Delisting:
- Participant requested withdrawal
- Participant Since
- 24 May 2010 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 30 June 2022
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 07-Jul-2021 | Communication on Progress 2020 | Active |
| 02-Mar-2021 | Communication on Progress 2019 | Active |
| 17-Mar-2020 | Communication on Progress 2018 | Active |
| 09-Jan-2020 | Grace Letter | Not applicable |
| 11-Jan-2019 | Communication on Progress 2017 | Active |
| 20-Sep-2018 | Grace Letter | Not applicable |
| 05-Oct-2017 | Communication on Progress 2016 | Active |
| 05-Sep-2017 | Grace Letter | Not applicable |
| 26-Aug-2016 | Communication on Progress | Active |
| 07-Jun-2016 | Grace Letter | Not applicable |
| 29-May-2015 | Communication on Progress | Active |
| 22-Jan-2015 | Communication on Progress | Active |
| 23-Oct-2014 | Grace Letter | Not applicable |
| 07-Oct-2013 | Communication on Progress | Active |
| 12-Sep-2012 | PharmaVision 2012 KİS Raporu | Active |
| 22-Aug-2011 | PharmaVision 2011 KİS Raporu | Active |
| 24-May-2011 | Grace Letter | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.